Skip to main content

Advertisement

Table 1 Characteristics according to age group

From: Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

  Age group Total
  <5 5–12 13–59 ≥60 NK  
  n = 610 (21.6%) n = 317 (11.2%) n = 1,716 (60.6%) n = 157 (5.5%) n = 31 (1.1%) N = 2,831
  n (%) n (%) n (%) n (%) n (%) n (%)
Gender
Male 315 (51.6) 151 (47.6) 606 (35.3) 48 (30.6) 16 (51.6) 1,136 (40.1)
Female 295 (48.4) 166 (52.4) 1,110 (64.7) 109 (69.4) 15 (48.4) 1,695 (59.9)
Facility type
Community pharmacy 4 (0.7) 1 (0.3) 18 (1.1) 3 (1.9) 0 (0) 26 (0.9)
Government 599 (98.2) 312 (98.4) 1,621 (94.5) 153 (97.5) 31 (100) 2,716 (95.9)
Private clinic 4 (0.7) 1 (0.3) 27 (1.6) 0 (0) 0 (0) 32 (1.1)
Quasi-government 3 (0.5) 3 (1.0) 50 (2.9) 1 (0.6) 0 (0) 57 (2.0)
Mode of diagnosis
Doctor 501 (82.1) 242 (76.4) 1,383 (80.6) 125 (79.6) 18 (58.1) 2,269 (80.2)
Laboratory Confirmation 20 (3.3) 19 (6.0) 48 (2.8) 3 (1.9) 1 (3.2) 91 (3.2)
Other health professional 18 (3.0) 22 (6.9) 127 (7.4) 8 (5.1) 5 (16.1) 180 (6.4)
Pharmacist 0 (0) 0 (0) 10 (0.6) 1 (0.6) 0 (0) 11 (0.4)
Self 0 (0) 2 (0.6) 6 (0.4) 0 (0) 0(0) 8 (0.3)
Unknown 71 (11.6) 32 (10.1) 142 (8.3) 20 (12.7) 7 (22.6) 272 (9.6)
Anti-malarial treatment prescribed
Combination therapy (ART-AQ) 161 (26.4) 181 (57.1) 790 (46.0) 76 (48.4) 9 (29.0) 1,217 (43.0)
Combination therapy (Other ACT) 240 (39.3) 40 (12.6) 124 (7.2) 5 (3.2) 9 (29.0) 418 (14.8)
Monotherapy (Artemisinin based) 111 (18.2) 55 (17.4) 700 (40.8) 61 (38.9) 9 (29.0) 936 (33.1)
Monotherapy (Non-artemisinin) 98 (16.1) 41 (12.9) 102 (5.9) 15 (9.6) 4 (12.9) 260 (9.2)
  1. NK = not known